Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of progressive pulmonary fibrosis (PPF) in adults.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback